Top compounds associated with response to TMEM191B


Feature Type Standardized
Nominal ANOVA
mRNA avrainvillamide CTRPv2 pan-cancer AAC -0.013 0.8
mRNA CIL41 CTRPv2 pan-cancer AAC -0.016 0.8
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.01 0.8
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC 0.05 0.8
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.012 0.8
mRNA AT13387 CTRPv2 pan-cancer AAC 0.014 0.8
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.0095 0.8
mRNA ML050 CTRPv2 pan-cancer AAC -0.011 0.8
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.0095 0.8
mRNA GSK-J4 CTRPv2 pan-cancer AAC -0.036 0.8
Download CSV